Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 1 EP application Alan Graff has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 15, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11763959

NEW TREATMENTS OF HEPATITIS C VIRUS INFECTION

IPC classification:
A61K 31/7056, A61K 38/13, A61K 38/21, A61K 45/06, A61P 31/14
Applicant:
Novartis AG
Agent:
Alan Graff, Novartis Pharma AG
Status:
APPLICATION DEEMED TO BE WITHDRAWN

Please Sign in to use this feature